Abstract
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
| Original language | English (US) |
|---|---|
| Article number | CD012816 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2017 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 30 2017 |
Bibliographical note
Publisher Copyright:© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS